Recently added articles from Instrument Business Outlook:
XRD flourishes in a broad market.
Sep 30, 2008 ... An X-ray diffraction (XRD) system transmits X-ray beams to a sample (generally a single crystal, metallic solid or a powder) and records the diffraction pattern that occurs when the X-ray photons encounter the inter-atomic gaps within the crystal structure. The results from the scattered ...
New R&D laboratories.
Sep 30, 2008 ... In the second installment of IBO's twice yearly look at new laboratories, we examine nonprofit projects in the US, new pharmaceutical and contract research organization (CRO) labs, as well as new food testing and food R&D labs. Nonprofits and Medical Schools The ...
GE buys microcalorimetry firm.(Executive Briefing: News & Views for Executives)(General Electric Co. GE Healthcare)(Brief article)
Sep 30, 2008 ... Chalfont St. Giles, England 9/30/08; Boston, MA 9/30/08--GE Healthcare has acquired MicroCal, a developer and manufacturer of microcalorimeters, for an undisclosed amount from majority owner Riverside Partners and other investors. MicroCal's 2008 revenues are estimated to be $28 million, ...
Invitrogen announces post-merger structure.(Executive Briefing: News & Views for Executives)
Sep 30, 2008 ... Carlsbad, CA 9/16/08; Carlsbad, CA and Foster City, CA 9/17/08; Carlsbad, CA 9/26/08--Invitrogen has completed the syndication of the $2.65 billion in financing for its acquisition of Applied Biosystems (ABI) (see IBO 6/15/08). Thirty bank lenders have committed to a Term Loan A in the ...
Fluidigm withdraws IPO.(Executive Briefing: News & Views for Executives)
Sep 30, 2008 ... New York, NY 9/22/08; South San Francisco, 9/26/08--Citing market instability, Fluidigm has withdrawn its registration statement for an IPO. Fluidigm, which develops microfluidic systems for drug development (see IBO 4/30/08), had originally planned to begin trading on September 19, but ...
Sequenom buys clinical diagnostic lab.(Executive Briefing: News & Views for Executives)(Center for Molecular Medicine)(Brief article)
Sep 30, 2008 ... San Diego, CA 9/23/08--Sequenom has agreed to acquire the Center for Molecular Medicine (CMM), a Clinical Laboratory Improvement Act-approved molecular pathology lab, for approximately $4.0 million, less CMM's cash at closing. Ninety percent of the purchase price will be paid in stock ....
All four IBO indexes follow market's decline.
Sep 30, 2008 ... On Monday, September 29, the US House of Representatives rejected the $700 billion bailout package, sending the Dow Jones Industrial Average, S&P 500 and NASDAQ down 7.0%, 8.8% and 9.1%, respectively. It was the largest single-day point decline for the Dow Jones in its history. The plan, ...
Clinical.(Industry Watch)(Brief article)
Sep 30, 2008 ... Clinical: Point-of-care testing (POCT) is contributing to the growth of the diagnostics product market. In the first six months of this year, the FDA approved 152 POC tests. LnteLab estimates that POCT represented 35% of the in vitro diagnostics market in 2005 and that, by 2011, it will ...
Biotechnology.(Industry Watch)(Brief article)
Sep 30, 2008 ... Biotechnology: This month, the FDA issued draft guidance on regulating genetically engineered animals (GE) for a 60-day comment period. AGE animal contains a heritable recombinant DNA (rDNA) construct that gives it new traits or characteristics. GE animals include animals that produce ...
Food.(Industry Watch)
Sep 30, 2008 ... Food: New rules for labeling fresh produce and meat by country of origin went into effect in the US on September 30. Manufactures have six months to comply with the rules. However, loopholes in the law exempt processed foods and mixed vegetables. In addition, labels on meat cuts can show ...
Energy.(Industry Watch)
Sep 30, 2008 ... Energy: According to Hydrocarbon Processing's HPI Construction Boxscore Survey, the total number of hydrocarbon projects worldwide grew 12% between June 2007 and June 2008 to 5,029. Rising the fastest were the number of synfuel projects, which grew 15%, while gas processing projects ...
South Africa.(Region Watch)(Brief article)
Sep 30, 2008 ... South Africa: According to South Africa's "National Survey of Research and Experimental Development: the country's gross domestic expenditure on R&D totaled ZAR 16,520.6 million ($1.95 billion), 0.95% of GDP, in 2006-2007 for a nominal annual increase of 16.8%. Engineering sciences, ...
India.(Region Watch)
Sep 30, 2008 ... India: India's Central Drugs Standard Control Organization (CDSCO) is preparing plans to enable foreign drug companies to conduct phase I clinical trials in the country, according to a government official. Currently, only Indian companies can conduct phase 0 and I trials domestically. KPMG ...
Sweden.(Region Watch)(Brief article)
Sep 30, 2008 ... Sweden: This month, Sweden announced the largest R&D investment in its history. The Swedish government's 2009 budget commits SEK 2.4 billion ($364 million) in 2009 to research funding. Such funding will reach SEK 5 billion in 2012. The funding includes the elimination of the value ...
Europe.(Region Watch)(Brief article)
Sep 30, 2008 ... Europe: New regulations designed to simplify pesticide residue laws in the EU took effect on September 1. The rules harmonize the maximum residue levels (MRLs) for pesticides and cover approximately 1,100 ...
Illumina partnered with Genpathway.(Microarrays: Company Announcements)
Sep 30, 2008 ... * Illumina partnered with Genpathway to ...
Illumina named its first certified genetic analysis service provider (CSPro) in Japan, Mitsubishi Chemical Safety Institute.(Microarrays: Company Announcements)
Sep 30, 2008 ... * Illumina named its first certified genetic analysis service provider (CSPro) in ...
Illumina.(Microarrays: Company Announcements)
Sep 30, 2008 ... * Illumina named Fredrick Cleric vice president, Quality Assurance and Regulatory Affairs. He was previously ...
Illumina.
Sep 30, 2008 ... * Illumina named Stephen Pentoney vice president of Array Biochemistry. He was most recently ...
Gentel Biosciences exclusively licensed PriTest's patent.(Microarrays: Company Announcements)
Sep 30, 2008 ... * Gentel Biosciences exclusively licensed PriTest's patent ...